natgillin/translations-raw huggingface dataset:
The claim proposed by the applicant was worded as follows: ‘Cocoa flavanols help maintain endothelium-dependent vasodilation which contributes to healthy blood flow’.
Vlagatelj je predlagal naslednjo trditev: „Kakavovi flavanoli pomagajo ohranjati širjenje žil, odvisno od endotelija, kar prispeva k zdravemu krvnemu obtoku.“
On 17 July 2012, the Commission and the Member States received the scientific opinion from the Authority which concluded that on the basis of the data presented a cause and effect relationship had been established between the consumption of cocoa flavanols and the claimed effect.
Komisija in države članice so 17. julija 2012 prejele znanstveno mnenje Agencije, ki je na podlagi predloženih podatkov ugotovila, da je vzročno-posledična povezava med uživanjem kakavovih flavanolov in navedeno trditvijo utemeljena.
The Authority indicated in its opinion that its conclusions could not have been reached without considering one human intervention study claimed by the applicant as proprietary.
Agencija je v svojem mnenju navedla, da do ugotovitev ne bi prišla brez upoštevanja intervencijske študije na ljudeh, za katero je vlagatelj zahteval zakonsko zaščito podatkov.
All the justifiable information provided by the applicant has been assessed by the Commission and it is considered that the requirements laid down in Article 21(1) of Regulation (EC) No 1924/2006 are fulfilled for the study claimed as proprietary.
Komisija je ocenila vse upravičljive informacije, ki jih je predložil vlagatelj, in sklenila, da so zahteve iz člena 21 (1) Uredbe (ES) št. 1924/2006 izpolnjene za študijo, za katero je vlagatelj zahteval zakonsko zaščito podatkov.
Accordingly, the scientific data and other information included in that study may not be used for the benefit of a subsequent applicant for a period of five years from the date of authorisation, under the conditions laid down in that Article.
Zato se znanstveni podatki in druge informacije iz navedene študije v skladu s pogoji iz navedenega člena ne smejo uporabiti v prid poznejšega vlagatelja v petih letih od datuma izdaje dovoljenja.
One of the objectives of Regulation (EC) No 1924/2006 is to ensure that health claims are truthful, clear and reliable and useful to the consumer, and that the wording and the presentation are taken into account in that respect.
Eden od ciljev Uredbe (ES) št. 1924/2006 je zagotoviti, da so zdravstvene trditve resnične, jasne, zanesljive in uporabne za potrošnika ter da se pri tem upoštevata besedilo in predstavitev trditve.
Therefore, where the wording of claims used by the applicant has the same meaning for consumers as that of an authorised health claim, because they demonstrate the same relationship that exists between a food category, a food or one of its constituents and health, they should be subject to the same conditions of use as those listed in the Annex to this Regulation.
Kadar ima besedilo trditev, ki ga uporabi vlagatelj, za potrošnike enak pomen kot odobrena zdravstvena trditev, ker predstavljata isto povezavo med kategorijo živila, živilom ali njegovo sestavino in zdravjem, bi bilo treba te trditve uporabljati pod enakimi pogoji uporabe, kot so navedeni v Prilogi k tej uredbi.
In accordance with Article 20 of Regulation (EC) No 1924/2006, the Register of nutrition and health claims containing all authorised health claims should be updated in order to take into account this Regulation.
V skladu s členom 20 Uredbe (ES) št. 1924/2006 bi bilo treba register prehranskih in zdravstvenih trditev, ki vsebuje vse odobrene zdravstvene trditve, posodobiti, da se upošteva ta uredba.
Since the applicants claim protection of proprietary data, it is considered appropriate to restrict the use of these claims in favour of the applicants for a period of five years.
Ker je vlagatelj zahteval zakonsko zaščito podatkov, je primerno, da se uporaba teh trditev omeji v korist vlagatelja za obdobje pet let.
However, the authorisation of these claims restricted for the use of an individual operator does not prevent other applicants from applying for authorisation to use the same claims in case the application is based on data and studies other than those protected under Article 21 of Regulation (EC) No 1924/2006.
Vendar odobritev teh trditev, ki je omejena za uporabo posameznega nosilca dejavnosti, ne preprečuje drugim vlagateljem, da zaprosijo za odobritev uporabe istih trditev v primeru, da vloga temelji na podatkih in študijah, ki niso zaščitene v skladu s členom 21 Uredbe (ES) št. 1924/2006.
The health claims set out in the Annex to this Regulation shall be included in the Union list of permitted claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.
Zdravstvene trditve iz Priloge k tej uredbi se uvrstijo na seznam dovoljenih trditev Unije v skladu s členom 13(3) Uredbe (ES) št. 1924/2006.
The use of health claims referred to in paragraph 1 shall be restricted to the applicants for a period of five years after the entry into force of this Regulation.
Uporaba zdravstvenih trditev iz odstavka 1 se omeji na vlagatelje za obdobje pet let po začetku veljavnosti te uredbe.
After the expiry of that period, those health claims may be used, in conformity with the conditions applying to them, by any food business operator.
Po poteku navedenega obdobja lahko navedene zdravstvene trditve v skladu s pogoji, ki zanje veljajo, uporabljajo vsi nosilci živilske dejavnosti.
The scientific data and other information included in the applications, which are claimed by the applicants as proprietary and without the submission of which the health claims could not have been authorised, are restricted for use for the benefit of the applicants for a period of five years from the date of entry into force of this Regulation under the conditions laid down in Article 21(1) of Regulation (EC) No 1924/2006.
Uporaba znanstvenih podatkov in drugih informacij iz vlog, za katere so vlagatelji zahtevali zaščito podatkov in brez predložitve katerih zdravstvena trditev ne bi mogla biti odobrena, je v skladu s pogoji iz člena 21(1) Uredbe (ES) št. 1924/2006 omejena v prid vlagatelja za pet let od datuma začetka veljavnosti te uredbe.
Done at Brussels, 3 September 2013.
V Bruslju, 3. septembra 2013
Commission Regulation (EU) No 432/2012 of 16 May 2012 establishing a list of permitted health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (OJ L 136, 25.5.2012, p. 1).
Uredba Komisije (EU) št. 432/2012 z dne 16. maja 2012 o seznamu dovoljenih zdravstvenih trditev na živilih, razen trditev, ki se nanašajo na zmanjšanje tveganja za nastanek bolezni ter na razvoj in zdravje otrok (UL L 136, 25.5.2012, str. 1).
In the Annex to Regulation (EU) No 432/2012, the following entries are inserted in an alphabetical order:
V Prilogi k Uredbi (EU) št. 432/2012 se po abecednem vrstnem redu vstavijo naslednji vnosi:
‘Reformulated, non-alcoholic, acidic drink with:
„Reformulirane, brezalkoholne, kisle pijače z:
less than 1 g fermentable carbohydrate per 100 ml (sugars and other carbohydrates except polyols),
manj kot 1 g fermentirajočih ogljikovih hidratov na 100 ml (sladkorji in drugi ogljikovi hidrati razen poliolov),
calcium in a range from 0,3 to 0,8 mol per mol acidulant,
kalcijem v razponu od 0,3 do 0,8 mola na mol sredstva za kisanje,
display of pH between 3,7-4,0.
prikaz pH med 3,7–4,0.
Replacing sugar-containing, acidic drinks, such as soft drinks (typically 8-12 g sugars/100 ml), with reformulated drinks contributes to the maintenance of tooth mineralisation [1]
Nadomeščanje kislih pijač, ki vsebujejo sladkor, kot so brezalkoholne pijače (tipično 8–12 g sladkorjev/100 ml), z reformuliranimi pijačami prispeva k ohranjanju mineralizacije zob [1].
In order to bear the claim, reformulated acidic drinks shall comply with the description of the food subject to the claim
Za uporabe te trditve so reformulirane kisle pijače skladne z opisom živila, za katerega se trditev uporablja.
Slowly digestible starch
Počasi prebavljiv škrob
Consumption of products high in slowly digestible starch (SDS) raises blood glucose concentration less after a meal compared to products low in SDS [2]
Uživanje proizvodov, ki vsebujejo veliko počasi prebavljivega škroba, manj poveča raven krvnega sladkorja po obroku kot proizvodi, ki vsebujejo malo počasi prebavljivega škroba [2].
The claim may be used only on food where the digestible carbohydrates provide at least 60 % of the total energy and where at least 55 % of those carbohydrates is digestible starch, of which at least 40 % is SDS
Trditev se lahko uporablja le za živila, v katerih prebavljivi ogljikovi hidrati predstavljajo vsaj 60 % skupne energije, od katerih predstavlja prebavljivi škrob vsaj 55 %, od tega je vsaj 40 % hitro prebavljivega škroba.
Cocoa flavanols
Kakavovi flavanoli
Cocoa flavanols help maintain the elasticity of blood vessels, which contributes to normal blood flow [3]
Kakavovi flavanoli pomagajo ohranjati prožnost žil, kar pripomore k normalnemu pretoku krvi [3].
Information shall be given to the consumer that the beneficial effect is obtained with a daily intake of 200 mg of cocoa flavanols.
Potrošnike se obvesti, da se koristni učinek doseže z dnevnim vnosom 200 mg kakavovih flavanolov.
The claim can be used only for cocoa beverages (with cocoa powder) or for dark chocolate which provide at least a daily intake of 200 mg of cocoa flavanols with a degree of polymerisation 1-10
Trditev se lahko uporablja le za kakavove pijače (s kakavom v prahu) ali za temno čokolado, ki zagotavljajo dnevni vnos vsaj 200 mg kakavovih flavanolov s stopnjo polimerizacije 1–10.
Authorised on 24.9.2013 restricted to the use of GlaxoSmithKline Services Unlimited and its affiliates, GSK House, 980 Great West Road, Brentford, TW89GS, United Kingdom, for a period of five years.
Odobreno dne 24. septembra 2013 in omejeno na uporabo podjetja GlaxoSmithKline Services Unlimited in njegovih podružnic, GSK House, 980 Great West Road, Brentford, TW89GS, Združeno kraljestvo, za pet let.
Authorised on 24.9.2013 restricted to the use of Mondelēz International group, Three Parkway North Deerfield, IL 60015, United States of America, for a period of five years.
Odobreno dne 24. septembra 2013 in omejeno na uporabo skupino Mondelēz International, Three Parkway North Deerfield, IL 60015, Združene države Amerike, za pet let.
Authorised on 24.9.2013 restricted to the use of Barry Callebaut Belgium NV, Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgium, for a period of five years.’
Odobreno dne 24. septembra 2013 in omejeno na uporabo podjetja Barry Callebaut Belgium NV., Aalstersestraat 122, B-9280 Lebbeke-Wieze, Belgija, za pet let.“
Determination of the postprandial responses to two cereal foods eaten alone or as part of a mixed meal,
Determination of the postprandial responses to two cereal foods eaten alone or as part of a mixed meal (Določitev post-prandialnih odzivov pri uživanju dveh žitnih živil, zaužitih samostojno ali kot del mešanega obroka),
Metabolic fate of four cereal products consumed as part of a breakfast by healthy female subjects,
Metabolic fate of four cereal products consumed as part of a breakfast by healthy female subjects (Presnova štirih žitnih proizvodov, zaužitih kot del zajtrka pri zdravih ženskah),
That study is Grassi D, Desideri G, Necozione S, Di Giosia P, Cheli P, Barnabei R, Allegaert L, Bernaert H and Ferri C, 2011.
Ta študija je: Grassi D, Desideri G, Necozione S, Di Giosia P, Cheli P, Barnabei R, Allegaert L, Bernaert H in Ferri C, 2011.
Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness and decreases blood pressure in healthy subjects.
Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness and decreases blood pressure in healthy subjects (Uživanje kakava v nadzorovanih odmerkih izboljša širjenje žil, povezano s pretokom, ter togost arterij in zniža krvni tlak pri zdravih posameznikih).
GlaxoSmithKline Report NHCMA0303, UK,
Poročilo GlaxoSmithKline NHCMA0303, Združeno kraljestvo,
GlaxoSmithKline Report NHCMA0301, UK,
Poročilo GlaxoSmithKline NHCMA0301, Združeno kraljestvo,
GlaxoSmithKline Report NHCMA0302, UK,
Poročilo GlaxoSmithKline NHCMA0302, Združeno kraljestvo,
GlaxoSmithKline Report NHCMA0401, UK,
Poročilo GlaxoSmithKline NHCMA0401, Združeno kraljestvo,
GlaxoSmithKline Report N1760182, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1760182, Združeno kraljestvo,
GlaxoSmithKline Report N1760183, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1760183, Združeno kraljestvo,
GlaxoSmithKline Report N1760184, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1760184, Združeno kraljestvo,
GlaxoSmithKline Report N1010201, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010201, Združeno kraljestvo,
GlaxoSmithKline Report N1010199, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010199, Združeno kraljestvo,
GlaxoSmithKline Report N1010200, UK,
(Enojno slepa, štirikrat križana študija za raziskavo učinka dveh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010200, Združeno kraljestvo,
GlaxoSmithKline Report N1010068, UK,
(Enojno slepa, petkrat križana študija za raziskavo učinka treh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010068, Združeno kraljestvo,
GlaxoSmithKline Report N1010104, UK,
(Enojno slepa, trikrat križana študija za raziskavo učinka formulacije sadne pijače v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog pri otrocih.) Poročilo GlaxoSmithKline N1010104, Združeno kraljestvo,
GlaxoSmithKline Report N1010021, UK,
(Enojno slepa, petkrat križana študija zdravih prostovoljcev za raziskavo učinka nove pomarančne in nove jagodne formulacije sadne pijače v primerjavi s sadno pijačo iz črnega ribeza in dveh kontrolnih odmerkov na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010021, Združeno kraljestvo,
Measurement of metabolic outcome of carbohydrates of two types of cereal products,
Measurement of metabolic outcome of carbohydrates of two types of cereal products (Meritev metaboličnega rezultata ogljikovih hidratov dveh vrst žitnih proizvodov),
Adams G, North M, De’Ath J. Principal Investigator: West NX, 2004.
Adams G, North M, De’Ath J. Glavni raziskovalec: West NX, 2004.
Adams G, North M. Principal Investigator Duggal MS, 2003.
Adams G, North M. Glavni raziskovalec Duggal MS, 2003.
Adnitt C, Adams G, North M. Principal Investigator Toumba KJ., 2005.
Adnitt C, Adams G, North M. Glavni raziskovalec Toumba KJ., 2005.
Broughton J, North, M, Roman L. Principal Investigator Toumba KJ., 2006.
Broughton J, North, M, Roman L. Glavni raziskovalec Toumba KJ., 2006.
Development of Intra-Oral Cariogenicity (ICT) Model #5.
Development of Intra-Oral Cariogenicity (Razvoj intraoralne kariogenosti) (ICT) Model #5.
De’Ath, J, North M, Smith S. Principal Investigator: Ong TJ., 2002a.
De’Ath, J, North M, Smith S. Glavni raziskovalec: Ong TJ., 2002a.
De’Ath J, North M, Smith S. Principal Investigator: Jackson R, 2002b.
De’Ath J, North M, Smith S. Glavni raziskovalec: Jackson R, 2002b.
De’Ath J, North M, Smith S. Principal Investigator: Preston A, 2002c.
De’Ath J, North M, Smith S. Glavni raziskovalec: Preston A, 2002c.
De’Ath J, Moohan M, Smith S. Principal Investigator: Toumba KJ, 2003.
De’Ath J, Moohan M, Smith S. Glavni raziskovalec: Toumba KJ, 2003.
Gard’ner K, Moohan M, Smith S. Principal Investigator: Ong TJ, 2003a.
Gard’ner K, Moohan M, Smith S. Glavni raziskovalec: Ong TJ, 2003a.
Gard’ner K, Moohan M, Smith S. Principal Investigator: Jackson R, 2003b.
Gard’ner K, Moohan M, Smith S. Glavni raziskovalec: Jackson R, 2003b.
Hollas M, McAuliffe T, Finke M. Principal Investigator: West NX, 2005.
Hollas M, McAuliffe T, Finke M. Glavni raziskovalec: West NX, 2005. An investigation into the effect of a modified blackcurrant drink on tooth enamel with and without additional tooth brushing.
May R, and Hughes JM.
May R, in Hughes JM.
Principal Investigator: Toumba KJ, 1998c.
Glavni raziskovalec: Toumba KJ, 1998c.
May R, and Moohan M. Principal Investigator: Duggal MS, 1999.
May R, in Moohan M. Glavni raziskovalec: Duggal MS, 1999.
A single blind, three-way crossover study to investigate the effect of a new formulation of fruit drink in comparison to a positive control (sucrose) and a negative control (sorbitol) on the pH of dental plaque in children.
A single blind, three-way crossover study to investigate the effect of a formulation of fruit drink in comparison to a positive control (sucrose) and a negative control (sorbitol) on the pH of dental plaque in children.
May R, Darby-Dowan A, Smith S. Principal Investigator: Curzon M, 1998a.
May R, Darby-Dowan A, Smith S. Glavni raziskovalec: Curzon M, 1998a.
Principal Investigator: Duggal MS, 1998b.
Glavni raziskovalec: Duggal MS, 1998b.
Brand-Miller JC, Holt S, Atkinson F, Fuzellier G and Agnetti V, 2006.
Brand-Miller JC, Holt S, Atkinson F, Fuzellier G in Agnetti V, 2006.
Laville M, Rabasa-Lhoret R, Normand S and Braesco V, 2005.
Laville M, Rabasa-Lhoret R, Normand S in Braesco V, 2005.
Rabasa-Lhoret R, Peronnet F, Jannot C, Fuzellier G and Gausseres N, 2007.
Rabasa-Lhoret R, Peronnet F, Jannot C, Fuzellier G in Gausseres N, 2007.
Vinoy S, Aubert R and Chapelot D, 2000.
Vinoy S, Aubert R in Chapelot D, 2000.
An investigation into the Erosive Effect of Hot Drinks.
An investigation into the Erosive Effect of Hot Drinks (Raziskava učinkov razjedanja pri vročih pijačah).
Development of Intra-Oral Cariogenicity (ICT) Model #3.
Development of Intra-Oral Cariogenicity (Razvoj intraoralne kariogenosti) (ICT) Model #3.
Development of Intra-Oral Cariogenicity (ICT) Model #4.
Development of Intra-Oral Cariogenicity (Razvoj intraoralne kariogenosti) (ICT) Model #4.
GlaxoSmithKline Report N1010067, UK.
(Enojno slepa, petkrat križana študija za raziskavo učinka treh formulacij sadnih pijač v primerjavi s pozitivno kontrolo (saharoza) in negativno kontrolo (sorbitol) na pH zobnih oblog.) Poročilo GlaxoSmithKline N1010067, Združeno kraljestvo.
A cereal product high in slowly available glucose increases subsequent satiety feelings and decreases glucose and insulin responses.
A cereal product high in slowly available glucose increases subsequent satiety feelings and decreases glucose and insulin responses (Žitni proizvod z visoko vsebnostjo počasi dostopne glukoze povečuje občutek sitosti in zmanjša raven glukoze in inzulina).
An investigation into the effect of a modified blackcurrant drink on tooth enamel with and without additional tooth brushing. GlaxoSmithKline Report NMA0501, UK,
(Raziskava učinka modificirane pijače iz črnega ribeza na zobno sklenino z dodatnim ščetkanjem zob in brez njega.) Poročilo GlaxoSmithKline NMA0501, Združeno kraljestvo,
Commission Implementing Regulation (EU) No 852/2013
Izvedbena uredba Komisije (EU) št. 852/2013
amending for the 200th time Council Regulation (EC) No 881/2002 imposing certain specific restrictive measures directed against certain persons and entities associated with the Al Qaida network
o dvestoti spremembi Uredbe Sveta (ES) št. 881/2002 o posebnih omejevalnih ukrepih za nekatere osebe in subjekte, povezane z mrežo Al-Kaida
On 26 August 2013 the Sanctions Committee of the United Nations Security Council (UNSC) decided to remove one natural person from its list of persons, groups and entities to whom the freezing of funds and economic resources should apply.
Odbor za sankcije Varnostnega sveta Združenih narodov je 26. avgusta 2013 sklenil črtati eno fizično osebo s seznama oseb, skupin in subjektov, za katere velja zamrznitev sredstev in gospodarskih virov.
‘Said Youssef Ali Abu Aziza (alias (a) Abdul Hamid, (b) Abu Therab). Date of birth: 1958. Place of birth: Tripoli, Libya. Nationality: Libyan. Passport number: (a) 87/437555 (Libyan passport), (b) 274381 (Libyan passport). Libyan national identification number: 145126. Other information: (a) Mother’s name is Fatima Isa, (b) Member of Libyan Islamic Fighting Group and Al-Qaida.
„Said Youssef Ali Abu Aziza (tudi (a) Abdul Hamid, (b) Abu Therab). Datum rojstva: 1958. Kraj rojstva: Tripoli, Libija. Državljanstvo: libijsko. Potni list št.: (a) 87/437555 (libijski potni list), (b) 274381 (libijski potni list). Libijska nacionalna identifikacijska številka: 145126. Drugi podatki: (a) ime matere je Fatima Isa, (b) član skupine Libyan Islamic Fighting Group in Al-Kaide. Datum uvrstitve iz člena 2a(4)(b): 8.6.2007.“
Commission Implementing Regulation (EU) No 853/2013
Izvedbena uredba Komisije (EU) št. 853/2013
Commission Implementing Regulation (EU) No 857/2013
Izvedbena uredba Komisije (EU) št. 857/2013
of 4 September 2013
z dne 4. septembra 2013
approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Mont d’Or/Vacherin du Haut-Doubs (PDO))
o odobritvi večje spremembe specifikacije za ime, vpisano v registru zaščitenih označb porekla in zaščitenih geografskih označb (Mont d’Or / Vacherin du Haut-Doubs (ZOP))
By virtue of the first subparagraph of Article 9(1) of Commission Regulation (EC) No 510/2006, the Commission has examined France’s application for the approval of amendments to the specification for the protected geographical indication ‘Mont d’Or/Vacherin du Haut-Doubs’ registered under Commission Regulation (EC) No 1107/96 [3], as amended by Regulation (EC) No 828/2003 [4].
Komisija je v skladu s prvim pododstavkom člena 9(1) Uredbe (ES) št. 510/2006 preučila vlogo Francije za odobritev spremembe specifikacije za zaščiteno označbo porekla „Mont d’Or“ / „Vacherin du Haut-Doubs“, registrirano v skladu z Uredbo Komisije (ES) št. 1107/96 [3], kakor je bila spremenjena z Uredbo Komisije (ES) št. 828/2003 [4].
Done at Brussels, 4 September 2013.
V Bruslju, 4. septembra 2013
OJ C 302, 6.10.2012, p. 16.
UL C 302, 6.10.2012, str. 16.
Mont d’Or/Vacherin du Haut-Doubs (PDO)
Mont d’Or / Vacherin du Haut-Doubs (ZOP)
Commission Implementing Regulation (EU) No 858/2013
Izvedbena uredba Komisije (EU) št. 858/2013
approving non-minor amendments to the specification for a name entered in the register of protected designations of origin and protected geographical indications (Nocciola del Piemonte/Nocciola Piemonte (PGI))
o odobritvi večje spremembe specifikacije za ime, vpisano v registru zaščitenih označb porekla in zaščitenih geografskih označb (Nocciola del Piemonte / Nocciola Piemonte (ZGO))
In accordance with the first subparagraph of Article 9(1) of Regulation (EC) No 510/2006, the Commission has examined Italy’s application for the approval of amendments to the specification for the protected geographical indication ‘Nocciola del Piemonte’/’Nocciola Piemonte’ registered under Commission Regulation (EC) No 1107/96 [3], as amended by Commission Regulation (EC) No 464/2004 [4].
Komisija je v skladu s prvim pododstavkom člena 9(1) Uredbe (ES) št. 510/2006 preučila vlogo Italije za odobritev spremembe specifikacije za zaščiteno geografsko označbo „Nocciola del Piemonte“ / „Nocciola Piemonte“, registrirano na podlagi Uredbe Komisije (ES) št. 1107/96 [3], kakor je bila spremenjena z Uredbo Komisije (ES) št. 464/2004 [4].
OJ L 77, 13.3.2004, p. 25.
UL L 77, 13.3.2004, str. 25.
OJ C 330, 27.10.2012, p. 17.
UL C 330, 27.10.2012, str. 17.